Exploring Microemulsion Systems for the Incorporation of Glucocorticoids into Bacterial Cellulose : A Novel Approach for Anti-Inflammatory Wound Dressings

GND
1312344857
ORCID
0000-0002-0455-6044
Affiliation
Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich Schiller University, 07743 Jena, Germany;(R.K.H.);(O.W.)
Zahel, Paul;
Affiliation
Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich Schiller University, 07743 Jena, Germany;(R.K.H.);(O.W.)
Bruggink, Vera;
GND
1323118837
ORCID
0009-0005-9754-4956
Affiliation
Institute of Biochemistry and Biophysics, Center for Molecular Biomedicine, Friedrich Schiller University, 07745 Jena, Germany;(J.H.);(T.H.)
Hülsmann, Juliana;
GND
1220324698
ORCID
0009-0001-4347-6178
Affiliation
Electron Microscopy Center, University Hospital Jena, Friedrich Schiller University, 07743 Jena, Germany;
Steiniger, Frank;
GND
1334890811
ORCID
0000-0002-1077-9703
Affiliation
Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich Schiller University, 07743 Jena, Germany;(R.K.H.);(O.W.)
Hofstetter, Robert K.;
GND
1211647552
Affiliation
Institute of Biochemistry and Biophysics, Center for Molecular Biomedicine, Friedrich Schiller University, 07745 Jena, Germany;(J.H.);(T.H.)
Heinzel, Thorsten;
GND
1223627691
ORCID
0000-0002-9839-5527
Affiliation
JeNaCell GmbH—An Evonik Company, 07745 Jena, Germany;(P.Z.);(V.B.);(U.B.)
Beekmann, Uwe;
GND
1022335375
ORCID
0000-0002-5064-4379
Affiliation
Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich Schiller University, 07743 Jena, Germany;(R.K.H.);(O.W.)
Werz, Oliver;
GND
131561332
Affiliation
JeNaCell GmbH—An Evonik Company, 07745 Jena, Germany;(P.Z.);(V.B.);(U.B.)
Kralisch, Dana

The effective pharmacological treatment of inflamed wounds such as pyoderma gangraenosum remains challenging, as the systemic application of suitable drugs such as glucocorticoids is compromised by severe side effects and the inherent difficulties of wounds as drug targets. Furthermore, conventional semi-solid formulations are not suitable for direct application to open wounds. Thus, the treatment of inflamed wounds could considerably benefit from the development of active wound dressings for the topical administration of anti-inflammatory drugs. Although bacterial cellulose appears to be an ideal candidate for this purpose due to its known suitability for advanced wound care and as a drug delivery system, the incorporation of poorly water-soluble compounds into the hydrophilic material still poses a problem. The use of microemulsions could solve that open issue. The present study therefore explores their use as a novel approach to incorporate poorly water-soluble glucocorticoids into bacterial cellulose. Five microemulsion formulations were loaded with hydrocortisone or dexamethasone and characterized in detail, demonstrating their regular microstructure, biocompatibility and shelf-life stability. Bacterial cellulose was successfully loaded with the formulations as confirmed by transmission electron microscopy and surprisingly showed homogenous incorporation, even of w/o type microemulsions. High and controllable drug permeation through Strat-M ® membranes was observed, and the anti-inflammatory activity for permeated glucocorticoids was confirmed in vitro. This study presents a novel approach for the development of anti-inflammatory wound dressings using bacterial cellulose in combination with microemulsions.

Cite

Citation style:
Could not load citation form.

Rights

License Holder: © 2024 by the authors.

Use and reproduction: